Sugammadex Sodium
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.
Detailed specifications, certificates, and supporting documents are available upon request.
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for accurate information.
Sugammadex Sodium Product Information
Sugammadex Sodium is listed under API and is intended for analytical research, quality control and pharmaceutical reference standard applications. The product is supplied by Clearsynth under CAT No. CS-O-12068.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
Sugammadex Sodium
CAS No.
343306-79-6
CAT No.
CS-O-12068
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
C72H104Na8O48S8
Molecular Weight
2178.01
Category
Storage Condition
Refer MSDS for complete information.
Hazard Compound
Refer MSDS for accurate information.
Description
Regulatory Description
Sugammadex Sodium is supplied with detailed characterization data compliant with regulatory guideline. Sugammadex Sodium can be used for analytical method development, method validation (AMV), Quality Control (QC), ANDA-related analytical work, and commercial pharmaceutical research applications.
Overview
Sugammadex Sodium is the first in a class of drugs called selective relaxant binding agents that offers improved termination of the paralytic effects of neuromuscular blocking agents and may have many potential peri-operative benefits.
Synonyms
Sugammadex Sodium
Application Notes
Sugammadex Sodium is the first in a class of drugs called selective relaxant binding agents that offers improved termination of the paralytic effects of neuromuscular blocking agents and may have many potential peri-operative benefits.
Product Applications & Regulatory Search Terms
Useful product, supplier and regulatory search terms for this reference standard.